BIFLAVONOIDS FROM LEAVES AND TWIGS OF INDONESIAN AGATHIS ROBUSTA (ARAUCARIACEAE) AND ITS BIOACTIVITY AS AN ANTICANCER
Cancer (malignant tumor) is one of the diseases with the second highest mortality rate in the world beside heart disease. Up to know, the research on cancer drugs particularly cancer drugs obtained from natural resources (terestial plants or marine organisms), grows rapidly since the good bioacti...
Saved in:
Main Author: | |
---|---|
Format: | Theses |
Language: | Indonesia |
Subjects: | |
Online Access: | https://digilib.itb.ac.id/gdl/view/32772 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Institut Teknologi Bandung |
Language: | Indonesia |
Summary: | Cancer (malignant tumor) is one of the diseases with the second highest mortality
rate in the world beside heart disease. Up to know, the research on cancer drugs
particularly cancer drugs obtained from natural resources (terestial plants or
marine organisms), grows rapidly since the good bioactive compounds for curing
cancer are limited and had side effects. One of the natural compound types which
have been known to have anticancer activity is biflavonoids or flavone dimers.
This compounds are composed of two monomer units of flavonoids, such as
apigenin or naringenin, which are joined through oxidative coupling reaction. This
reaction can produce several biflavonoid skeletons, such as agathisflavone (A),
amentoflavone (B), cupressuflavone (C), robustaflavone (D), and hinokiflavone
(E) having differences in bond linkage of two monomers, either through C-C or
C-O-C bond. Previous researches have been reported that biflavonoids have high
activity against several cancer cells, including lung carcinoma cells NCI-H460
and renal carcinoma cells RXF-393. In addition, these compounds have also been
known to have various activities, such as anti-HIV, anti-malarial, antidepressant,
antiepileptic, antituberculosis, antiimflamatory, antiherpes, antiinfluenza, hepatitis
B virus replication inhibitor, and beta secretase (BACE-1) enzyme inhibitor as an
anti-Alzheimer's. One of Indonesian plants which have known to have
biflavonoids is Agathis (Araucariaceae). This genus is often found as evergreen
tree distributing in Australia and Indomalaya, such as Indonesia (Kalimantan and
Irian Jaya), Papua New Guinea, and New Caledonia. A. robusta is one of five
species from Agathis genus which grows well in Indonesia, especially in Java and
Kalimantan Island. This species has a high economic value for its wood and resin
which can be used for industrial purposes, such as paper and furniture industries.
Moreover, this species also has ecological function as the city lungs. However,
there are no recent studies have been reported on secondary metabolites,
especially biflavonoids, from Indonesian A. robusta. Even though biflavonoids
have been known to have anticancer activities, but the activities on HUVEC
(Human Umbilical Vein Endothelial Cells) proliferation and murine leukemia
cells P-388 have not reported yet. Therefore, this research has been conducted to isolate biflavonoid from leaves and twigs of Indonesian A. robusta using
extraction methods and various chromatographic techniques, such as vacuum
liquid chromatography, radial chromatography, gravity column chromatography
with silica gel and Sephadex LH-20 as a stationary phase. Furthermore, the
extracts and secondary metabolites isolated were also examined on
antiangiogenesis as HUVEC (Human Umbilical Vein Endothelial Cells)
proliferation inhibitor and cytotoxic activity against murine leukemia P-388 cells.
Fourteen compounds which are nine biflavonoid compounds have been
successfully obtained from the acetone extract of A. robusta leaves and twigs. All
compounds were elucidated according their spectroscopic data, including IR, UVVis,
NMR (1H, 13C, NOESY, HSQC, and HMBC), MS, and CD Spectra as 7,7“-
di-O-methylagathisflavone (11); 4“‘,7,7“-tri-O-methylagathisflavone (12);
kayaflavone (13); 4‘,4“‘,7,7“-tetra-O-methylamentoflavone (14); 7,7“-di-Omethylcupressuflavone
(15); 4‘,4“‘,7,7“-tetra-O- methylcupressuflavone (16); 7“ -
mono-O-methylrobustaflavone (17); 4‘,7“-di-O-methylrobustaflavone (18), and
imbrikataflavone (19). The preliminary HUVEC proliferation assay of acetone
extract of the leaves and twigs of A. robusta showed weak activity with IC50
values were 35.0 and 29.0 ?g/mL, respectively. Then, four biflavonoid
compounds have also been assayed on HUVEC proliferation and indicated that
compound (17) and (15) were active with IC50 values were 2.1 and 3.3 ?g/mL,
respectively; compound (14) showed weak activity with IC50 value was 73.0
?g/mL; and compound (16) was not active on HUVEC proliferation with IC50
values more than 100.0 ?g/mL. Furthermore, the preliminary assay of acetone
extract of A. robusta leaves on cytotoxic against murine leukemia P-388 cells
showed inactive with IC50 value was 46.0 ?g/mL. Interestingly, the acetone
extract of A. robusta twigs was active with IC50 value of 17.6 ?g/mL. Five
biflavonoid compounds have also been examined their cytotoxicity against murine
leukemia P-388 cells. Compound (17) was very active with IC50 values less than
0.1 ?g/mL. In addition, compound (15) showed active activity with IC50 value
was 1.8 ?g/mL. Three other compounds, (19), (16), and (14) and were inactive
with IC50 values 44.5, 70.5, and > 100.0 ?g/mL. Thus, it can be suggested that the
compound (15) and (17) are potential to be the lead compounds for anticancer. |
---|